306 related articles for article (PubMed ID: 27531277)
61. May omega-3 fatty acid dietary supplementation help reduce severe complications in Covid-19 patients?
Weill P; Plissonneau C; Legrand P; Rioux V; Thibault R
Biochimie; 2020 Dec; 179():275-280. PubMed ID: 32920170
[TBL] [Abstract][Full Text] [Related]
62. Combined Buckwheat d-Fagomine and Fish Omega-3 PUFAs Stabilize the Populations of Gut
Hereu M; Ramos-Romero S; Marín-Valls R; Amézqueta S; Miralles-Pérez B; Romeu M; Méndez L; Medina I; Torres JL
Nutrients; 2019 Oct; 11(11):. PubMed ID: 31683529
[TBL] [Abstract][Full Text] [Related]
63. Effects of the combination of ω-3 PUFAs and proanthocyanidins on the gut microbiota of healthy rats.
Ramos-Romero S; Hereu M; Molinar-Toribio E; Almajano MP; Méndez L; Medina I; Taltavull N; Romeu M; Nogués MR; Torres JL
Food Res Int; 2017 Jul; 97():364-371. PubMed ID: 28578061
[TBL] [Abstract][Full Text] [Related]
64. High levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactation.
Weiss GA; Troxler H; Klinke G; Rogler D; Braegger C; Hersberger M
Lipids Health Dis; 2013 Jun; 12():89. PubMed ID: 23767972
[TBL] [Abstract][Full Text] [Related]
65. An update on the role of omega-3 fatty acids on inflammatory and degenerative diseases.
Lorente-Cebrián S; Costa AG; Navas-Carretero S; Zabala M; Laiglesia LM; Martínez JA; Moreno-Aliaga MJ
J Physiol Biochem; 2015 Jun; 71(2):341-9. PubMed ID: 25752887
[TBL] [Abstract][Full Text] [Related]
66. Sex-specific responses in glucose-insulin homeostasis and lipoprotein-lipid components after high-dose supplementation with marine n-3 PUFAs in abdominal obesity: a randomized double-blind crossover study.
Laupsa-Borge J; Grytten E; Bohov P; Bjørndal B; Strand E; Skorve J; Nordrehaug JE; Berge RK; Rostrup E; Mellgren G; Dankel SN; Nygård OK
Front Nutr; 2023; 10():1020678. PubMed ID: 37404855
[TBL] [Abstract][Full Text] [Related]
67. Anti-inflammatory properties of omega-3 fatty acids in critical illness: novel mechanisms and an integrative perspective.
Singer P; Shapiro H; Theilla M; Anbar R; Singer J; Cohen J
Intensive Care Med; 2008 Sep; 34(9):1580-92. PubMed ID: 18461305
[TBL] [Abstract][Full Text] [Related]
68. Reduced intestinal FADS1 gene expression and plasma omega-3 fatty acids following Roux-en-Y gastric bypass.
Garla P; Sala P; Torrinhas RSM; Machado NM; Fonseca DC; da Silva MM; Ravacci GR; Belarmino G; Ishida RK; Guarda IFMS; de Moura EGH; Sakai P; Santo MA; da Silva IDCG; Pereira CCA; Heymsfield S; Corrêa-Giannella MLC; Calder PC; Waitzberg DL
Clin Nutr; 2019 Jun; 38(3):1280-1288. PubMed ID: 30459098
[TBL] [Abstract][Full Text] [Related]
69. Activation of Lipid Mediator Formation Due to Lipoprotein Apheresis.
Weylandt KH; Schmöcker C; Ostermann AI; Kutzner L; Willenberg I; Kiesler S; Steinhagen-Thiessen E; Schebb NH; Kassner U
Nutrients; 2019 Feb; 11(2):. PubMed ID: 30744123
[TBL] [Abstract][Full Text] [Related]
70. The role of omega-3 derived resolvins in arthritis.
Norling LV; Perretti M
Curr Opin Pharmacol; 2013 Jun; 13(3):476-81. PubMed ID: 23434193
[TBL] [Abstract][Full Text] [Related]
71. Omega-3 polyunsaturated fatty acids improve endothelial function in humans at risk for atherosclerosis: A review.
Zehr KR; Walker MK
Prostaglandins Other Lipid Mediat; 2018 Jan; 134():131-140. PubMed ID: 28802571
[TBL] [Abstract][Full Text] [Related]
72. Significance of long chain polyunsaturated fatty acids in human health.
Zárate R; El Jaber-Vazdekis N; Tejera N; Pérez JA; Rodríguez C
Clin Transl Med; 2017 Dec; 6(1):25. PubMed ID: 28752333
[TBL] [Abstract][Full Text] [Related]
73. ω-3PUFA supplementation ameliorates adipose tissue inflammation and insulin-stimulated glucose disposal in subjects with obesity: a potential role for apolipoprotein E.
Hernandez JD; Li T; Rau CM; LeSuer WE; Wang P; Coletta DK; Madura JA; Jacobsen EA; De Filippis E
Int J Obes (Lond); 2021 Jun; 45(6):1331-1341. PubMed ID: 33753887
[TBL] [Abstract][Full Text] [Related]
74. Role of specialized pro-resolving mediators on inflammation, cardiometabolic health, disease progression, and quality of life after omega-3 PUFA supplementation and aerobic exercise training in individuals with rheumatoid arthritis: a randomized 16-week, placebo-controlled interventional trial.
Jannas-Vela S; Candia AA; Peñailillo L; Barrios-Troncoso P; Zapata-Urzúa J; Rey-Puente J; Aukema HM; Mutch DM; Valenzuela R; Valladares-Ide D
F1000Res; 2023; 12():942. PubMed ID: 38778807
[No Abstract] [Full Text] [Related]
75. Ratio of pro-resolving and pro-inflammatory lipid mediator precursors as potential markers for aggressive periodontitis.
Elabdeen HR; Mustafa M; Szklenar M; Rühl R; Ali R; Bolstad AI
PLoS One; 2013; 8(8):e70838. PubMed ID: 23951021
[TBL] [Abstract][Full Text] [Related]
76. Effect of DHA supplementation in a very low-calorie ketogenic diet in the treatment of obesity: a randomized clinical trial.
de Luis D; Domingo JC; Izaola O; Casanueva FF; Bellido D; Sajoux I
Endocrine; 2016 Oct; 54(1):111-122. PubMed ID: 27117144
[TBL] [Abstract][Full Text] [Related]
77. n-3 Fatty acids as resolvents of inflammation in the A549 cells.
Gdula-Argasińska J; Czepiel J; Woźniakiewicz A; Wojtoń K; Grzywacz A; Woźniakiewicz M; Jurczyszyn A; Perucki W; Librowski T
Pharmacol Rep; 2015 Jun; 67(3):610-5. PubMed ID: 25933977
[TBL] [Abstract][Full Text] [Related]
78. Polyunsaturated fatty acids, specialized pro-resolving mediators, and targeting inflammation resolution in the age of precision nutrition.
Al-Shaer AE; Buddenbaum N; Shaikh SR
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Jul; 1866(7):158936. PubMed ID: 33794384
[TBL] [Abstract][Full Text] [Related]
79. Effects of EPA and lipoic acid supplementation on circulating FGF21 and the fatty acid profile in overweight/obese women following a hypocaloric diet.
Escoté X; Félix-Soriano E; Gayoso L; Huerta AE; Alvarado MA; Ansorena D; Astiasarán I; Martínez JA; Moreno-Aliaga MJ
Food Funct; 2018 May; 9(5):3028-3036. PubMed ID: 29766165
[TBL] [Abstract][Full Text] [Related]
80. Role of omega-3 fatty acids in obesity, metabolic syndrome, and cardiovascular diseases: a review of the evidence.
Lorente-Cebrián S; Costa AG; Navas-Carretero S; Zabala M; Martínez JA; Moreno-Aliaga MJ
J Physiol Biochem; 2013 Sep; 69(3):633-51. PubMed ID: 23794360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
